These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9071423)

  • 21. Histological aspects of sexually transmitted genital lesions.
    Freinkel AL
    Histopathology; 1987 Aug; 11(8):819-31. PubMed ID: 3623440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chancroid. Recent advances in treatment and control.
    Ronald AR
    Int J Dermatol; 1986; 25(1):31-3. PubMed ID: 3485081
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the hyperimmune reaction in chancroid; effect of ACTH.
    TYLER DE
    U S Armed Forces Med J; 1956 May; 7(5):663-70. PubMed ID: 13312156
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous single-dose ceftriaxone treatment of chancroid.
    Hartmann AA; Elsner P; Burg G
    Dermatologica; 1991; 183(2):132-5. PubMed ID: 1743374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chancroid.
    Felman YM; Nikitas JA
    Cutis; 1980 Nov; 26(5):464-78. PubMed ID: 7460616
    [No Abstract]   [Full Text] [Related]  

  • 27. Chancroid in Nigeria.
    Joshi RM; Lawande RV
    Trans R Soc Trop Med Hyg; 1983; 77(5):665-7. PubMed ID: 6606880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
    Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
    Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin.
    Tyndall MW; Agoki E; Plummer FA; Malisa W; Ndinya-Achola JO; Ronald AR
    Sex Transm Dis; 1994; 21(4):231-4. PubMed ID: 7974076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Image of the month. Combined chancre, a soft chancroid and a syphilitic chancre].
    Henry F; Devillers C; Szepetiuk G; Piérard GE
    Rev Med Liege; 2009 Apr; 64(4):177-8. PubMed ID: 19514534
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriological study of chancroid.
    Choudhary BP; Kumari S; Bhatia R; Agarwal DS
    Indian J Med Res; 1982 Sep; 76():379-85. PubMed ID: 6983497
    [No Abstract]   [Full Text] [Related]  

  • 32. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi.
    Ndinya-Achola JO; Kihara AN; Fisher LD; Krone MR; Plummer FA; Ronald A; Holmes KK
    Int J STD AIDS; 1996; 7(3):201-5. PubMed ID: 8799783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chancroid with a single dose of spectinomycin.
    Guzmán M; Guzmán J; Bernal M
    Sex Transm Dis; 1992; 19(5):291-4. PubMed ID: 1411847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftriaxone no longer predictably cures chancroid in Kenya.
    Tyndall M; Malisa M; Plummer FA; Ombetti J; Ndinya-Achola JO; Ronald AR
    J Infect Dis; 1993 Feb; 167(2):469-71. PubMed ID: 8421184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chancroid: contemporary appraisal.
    Sehgal VN; Srivastava G
    Int J Dermatol; 2003 Mar; 42(3):182-90. PubMed ID: 12653911
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morphologic variants of genital ulcer caused by Haemophilus ducreyi].
    Ballard RC; Abeck D; Korting HC; Dangor Y; Braun-Falco O
    Hautarzt; 1989 Jul; 40(7):443-7. PubMed ID: 2788154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eradicating chancroid.
    Steen R
    Bull World Health Organ; 2001; 79(9):818-26. PubMed ID: 11584729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1.
    Tyndall MW; Plourde PJ; Agoki E; Malisa W; Ndinya-Achola JO; Plummer FA; Ronald AR
    Am J Med; 1993 Mar; 94(3A):85S-88S. PubMed ID: 8452188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.